AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism

AngioDynamics, Inc. , a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced the...

Related Keywords

United States ,American ,Machanahalli Balakrishna ,Mona Ranade ,Juan Carlos Serna ,William Brent Keeling ,Angiodynamics Inc ,Nasdaq ,Scientific Affairs ,David Geffen School Of Medicine ,Company Alphavac Multipurpose Mechanical Aspiration ,Department Of Surgery ,American Heart Association ,Product Service ,Emory University School Of Medicine ,Pulmonary Embolism Response Team ,Dynamics Completes Patient Enrollment ,Acute Pulmonary Embolism Extraction Trial ,Alphavac System ,Alphavac Multipurpose Mechanical Aspiration ,Angiodynamic Senior Vice President ,Investigational Device Exemption ,Major Adverse Events ,Associate Professor ,Emory University School ,Immediate Past President ,Principal Investigators William Brent Keeling ,Assistant Professor ,Interventional Radiology ,David Geffen School ,Private Securities Litigation Reform Act ,Annual Report ,Acute Pulmonary Embolism ,Current Status ,Scientific Statement From The American Heart ,About Pulmonary ,Risk Pulmonary Embolism ,Contemporary Diagnosis ,Risk Stratification ,